Evolent Health, Inc
EVH Healthcare Health Information Services
Evolent Health, Inc’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 26.6% from fiscal 2024. In the quarter to June 2026, revenue grew 46.9%, EPS grew 43.2%, free cash flow grew 58.7% and total debt rose 49.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow EVH
Evolent Health, Inc (EVH) P/E ratio
Evolent Health, Inc has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 1.4× (August 2015) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 41 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDRX Veradigm Inc. compare | n/m |
| SOPH SOPHiA GENETICS SA compare | n/m |
| CSLT Castlight Health, inc. compare | n/m |
| EVH Evolent Health, Inc | n/m |
| WEAV Weave Communications, Inc. compare | n/m |
| CTEV Claritev Corporation compare | n/m |
| CARL Carlsmed, Inc. compare | n/m |
| PHR Phreesia, Inc. compare | 64.4× |
| NRC National Research Corporation compare | 80.6× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)